articleTop 1% cited

Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion

Ophthalmology · 2010 · Vol. 117(6) · pp. 1134–1146.e3

Julia A. Haller✉(Wills Eye Hospital)Francesco Bandello(Ospedale Maggiore)Rubens Belfort(Universidade Federal de São Paulo)Mark S. Blumenkranz(Stanford University)Mark C. Gillies(University of Sydney)Jeffrey S. Heier(Ophthalmic Consultants of Boston)Anat LoewensteinYoung‐Hee Yoon(Asan Medical Center)Marie-Louise Jacques(Allergan (United States))Jenny Jiao(Allergan (United States))Xiaoyan Li(Allergan (United States))Scott M. Whitcup(Allergan (United States))

View via DOI Publisher page

Retinal Diseases and Treatments Retinal and Optic Conditions Retinal Imaging and AnalysisMedicineMacular edemaDexamethasoneRetinal VeinOphthalmologyRandomized controlled trialOcclusionCentral retinal vein occlusionImplantEdema

MeSH terms

AdultAgedAged, 80 and overDexamethasoneDouble-Blind MethodDrug ImplantsFemaleGlucocorticoidsHumansMacular EdemaMaleMiddle AgedProspective StudiesRetinal Vein OcclusionVisual Acuity

Citations

1,061

FWCI

71.90

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant